Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 2,681 Shares

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,681 shares of the firm’s stock in a transaction on Wednesday, January 8th. The shares were sold at an average price of $27.95, for a total transaction of $74,933.95. Following the sale, the chief operating officer now owns 769,993 shares in the company, valued at approximately $21,521,304.35. This trade represents a 0.35 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Evan Roberts also recently made the following trade(s):

• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53.
• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total value of $38,758.29.

Phreesia Trading Down 5.9 %

Shares of PHR traded down $1.68 during mid-day trading on Friday, hitting $26.75. 625,124 shares of the company’s stock traded hands, compared to its average volume of 446,504. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $1.55 billion, a P/E ratio of -18.20 and a beta of 0.94. The business’s 50-day moving average price is $22.70 and its 200-day moving average price is $22.57. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same period in the previous year, the firm earned ($0.58) EPS. The company’s quarterly revenue was up 16.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Phreesia, Inc. will post -1.16 EPS for the current fiscal year.

Institutional Trading of Phreesia

Institutional investors and hedge funds have recently bought and sold shares of the stock. International Assets Investment Management LLC lifted its position in Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares during the period. Lombard Odier Asset Management USA Corp purchased a new position in Phreesia during the second quarter valued at $202,000. Point72 DIFC Ltd bought a new stake in Phreesia in the second quarter worth $209,000. XTX Topco Ltd purchased a new stake in shares of Phreesia in the third quarter worth $247,000. Finally, Hsbc Holdings PLC bought a new position in shares of Phreesia during the second quarter valued at $301,000. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on PHR. KeyCorp raised their price objective on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday. Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of Phreesia in a research note on Friday. Truist Financial upped their price objective on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Finally, Robert W. Baird cut their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.